Clinical Trial Update: A Safety and Efficacy Study of SABER®-Bupivacaine for Pain Following Hernia Repair [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating SABER®-Bupivacaine for postoperative pain after hernia repair has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hernia
• Postoperative Pain

Drugs mentioned

• SABER®-Bupivacaine (bupivacaine)

Snippet

Sponsor: Durect | Conditions: Postoperative Pain, Hernia | Phase 2 | Status: COMPLETED | Results posted: 2021-05-05